{"id":"https://openalex.org/W2160329331","doi":"https://doi.org/10.1200/jco.2007.11.0106","title":"Trastuzumab-Related Cardiotoxicity: Calling Into Question the Concept of Reversibility","display_name":"Trastuzumab-Related Cardiotoxicity: Calling Into Question the Concept of Reversibility","publication_year":2007,"publication_date":"2007-08-08","ids":{"openalex":"https://openalex.org/W2160329331","doi":"https://doi.org/10.1200/jco.2007.11.0106","mag":"2160329331","pmid":"https://pubmed.ncbi.nlm.nih.gov/17687157"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.11.0106","doi":"https://doi.org/10.1200/jco.2007.11.0106","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.11.0106","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2160329331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052487618","display_name":"Melinda L. Telli","orcid":"https://orcid.org/0000-0001-7993-1235","observed_orcids":["https://orcid.org/0000-0001-7993-1235"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda L. Telli","raw_affiliation_strings":["From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112739478","display_name":"Sharon A. Hunt","orcid":"https://orcid.org/0009-0007-1647-5210","observed_orcids":["https://orcid.org/0009-0007-1647-5210"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon A. Hunt","raw_affiliation_strings":["From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011608816","display_name":"Robert W. Carlson","orcid":"https://orcid.org/0000-0003-2011-6695","observed_orcids":["https://orcid.org/0000-0003-2011-6695"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert W. Carlson","raw_affiliation_strings":["From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076148156","display_name":"Alice E. Guardino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice E. Guardino","raw_affiliation_strings":["From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Division of Medical Oncology and Division of Cardiovascular Medicine, Stanford University, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":23.6566,"has_fulltext":false,"cited_by_count":393,"citation_normalized_percentile":{"value":0.99644702,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"25","issue":"23","first_page":"3525","last_page":"3533"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.9430000185966492},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cardiac-follow-up","display_name":"cardiac follow-up","score":0.7490000128746033},{"id":"https://openalex.org/keywords/early-stopping-rules","display_name":"early stopping rules","score":0.5720000267028809},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9535423517227173},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.946200966835022},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9276342391967773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.586560070514679},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5782721042633057},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5370563268661499},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.49691489338874817},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4781535565853119},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47741591930389404},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.4767621159553528},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4363696575164795},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39796996116638184},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2014937400817871}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006331","descriptor_name":"Heart Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018487","descriptor_name":"Ventricular Dysfunction, Left","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D018487","descriptor_name":"Ventricular Dysfunction, Left","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/jco.2007.11.0106","doi":"https://doi.org/10.1200/jco.2007.11.0106","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.11.0106","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:17687157","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17687157","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.990.596","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.990.596","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://hwmaint.jco.ascopubs.org/cgi/reprint/25/23/3525.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1963592300","https://openalex.org/W1982210988","https://openalex.org/W2000798782","https://openalex.org/W2016183255","https://openalex.org/W2029542561","https://openalex.org/W2036752075","https://openalex.org/W2050674912","https://openalex.org/W2052889356","https://openalex.org/W2093332042","https://openalex.org/W2095156669","https://openalex.org/W2107427447","https://openalex.org/W2109775164","https://openalex.org/W2119130035","https://openalex.org/W2136566853","https://openalex.org/W2140074016","https://openalex.org/W2141393790","https://openalex.org/W2144124503","https://openalex.org/W2146384083","https://openalex.org/W2149908785","https://openalex.org/W2318605753","https://openalex.org/W2399215084","https://openalex.org/W2469805673","https://openalex.org/W2760092279","https://openalex.org/W2991727693","https://openalex.org/W3023522280"],"related_works":["https://openalex.org/W7096507652","https://openalex.org/W2133553644","https://openalex.org/W2322365111","https://openalex.org/W2317296253","https://openalex.org/W2243356516","https://openalex.org/W2248113534","https://openalex.org/W2765800912","https://openalex.org/W2015038969","https://openalex.org/W2999854007","https://openalex.org/W2262953609"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"assess":[2],"the":[3,8,12,22,30,67,96,100,113,164,194],"spectrum":[4],"and":[5,19,35,54,236],"reversibility":[6],"of":[7,21,71,80,88,98,109,133,143,151,157,161,171,181,185,191,204,247,251],"cardiotoxicity":[9,59,82,134,152,192],"observed":[10],"in":[11,103,163,174,193,209],"adjuvant":[13,24,114],"trastuzumab":[14,25,101,115,169,218],"trials.":[15,57],"DESIGN:":[16],"The":[17,58,85],"design":[18],"efficacy":[20],"major":[23],"trials":[26,116,147],"was":[27,93],"assessed,":[28],"including":[29],"National":[31],"Surgical":[32],"Adjuvant":[33,217],"Breast":[34,48],"Bowel":[36],"Project":[37],"(NSABP)":[38],"B-31,":[39],"North":[40],"Central":[41],"Cancer":[42,49],"Treatment":[43],"Group":[44,52],"N9831,":[45],"Herceptin":[46,56],"Adjuvant,":[47],"International":[50],"Research":[51],"006,":[53],"Finland":[55],"data":[60],"were":[61,74,83,135],"evaluated":[62],"with":[63,76,95,188,224],"a":[64,140,200,241],"focus":[65],"on":[66,145],"follow-up":[68,182,246],"cardiac":[69,183,245],"evaluations":[70,184],"women":[72,249],"who":[73],"diagnosed":[75,187],"cardiotoxicity.":[77],"Proposed":[78],"mechanisms":[79],"trastuzumab-related":[81],"considered.":[84],"natural":[86],"history":[87],"congestive":[89],"heart":[90],"failure":[91],"(CHF)":[92],"reviewed":[94],"goal":[97],"placing":[99],"experience":[102],"context.":[104],"RESULTS:":[105],"Up":[106],"to":[107,212,222],"4%":[108],"patients":[110,144,162,186,205,223],"enrolled":[111],"onto":[112],"experienced":[117,148],"severe":[118],"CHF":[119],"during":[120],"treatment.":[121],"In":[122],"these":[123,146,248],"trials,":[124],"early":[125],"stopping":[126],"rules":[127],"that":[128,153,199],"identified":[129],"an":[130],"unacceptable":[131],"level":[132],"never":[136],"reached.":[137],"Despite":[138],"this,":[139],"large":[141],"number":[142],"some":[149],"form":[150],"ultimately":[154],"required":[155],"discontinuation":[156],"trastuzumab.":[158],"Approximately":[159],"14%":[160],"NSABP":[165,195],"B-31":[166,196],"trial":[167,197],"discontinued":[168],"because":[170],"asymptomatic":[172],"decreases":[173],"left":[175],"ventricular":[176],"ejection":[177],"fraction":[178],"(LVEF).":[179],"Results":[180],"any":[189],"degree":[190],"document":[198],"clinically":[201],"significant":[202],"proportion":[203],"have":[206],"sustained":[207],"decrements":[208],"their":[210],"LVEF":[211],"less":[213],"than":[214],"50%.":[215],"CONCLUSION:":[216],"provides":[219],"substantial":[220],"benefits":[221],"human":[225],"epidermal":[226],"growth":[227],"factor":[228],"receptor":[229],"2-positive":[230],"breast":[231],"cancer,":[232],"however,":[233],"competing":[234],"immediate":[235],"long-term":[237],"cardiovascular":[238],"risks":[239],"are":[240],"great":[242],"concern.":[243],"Continued":[244],"is":[250],"critical":[252],"importance.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":20},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":25},{"year":2016,"cited_by_count":38},{"year":2015,"cited_by_count":32},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":32},{"year":2012,"cited_by_count":25}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
